معرفی
William W.L. Wong is an Associate Professor and the CIHR Applied Public Health Chair in HIV and STBBI Research at the University of Waterloo. His work focuses on pharmacoeconomics, pharmacoinformatics, and health technology assessment, with a particular emphasis on infectious diseases like hepatitis C, HIV/AIDS, and public health policy. He has contributed to studies evaluating cost-effectiveness of treatments, healthcare resource allocation, and interventions targeting marginalized populations.
- Specializes in cost-utility analyses of novel therapies (e.g., CAR T-cell treatments, antivirals).
- Expert in hepatitis C elimination strategies, screening programs, and disparities in healthcare access.
- Leads research on opioid overdose prevention (e.g., naloxone distribution) and pandemic healthcare resource use.
His recent work highlights trends in hepatitis C care cascades, maternal healthcare gaps, and the economic impact of expanding access to treatments. Wong collaborates with policymakers to design evidence-based public health interventions, particularly for immigrant and high-risk populations.
- Key areas include: viral hepatitis epidemiology, healthcare cost-benefit analysis, and global health equity.
- Publications span over 70 peer-reviewed articles, emphasizing methodological rigor in health technology assessment.
